We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$2.23B
AUM Growth
+$1.22B
Cap. Flow
+$1.34B
Cap. Flow %
60.06%
Top 10 Hldgs %
26.38%
Holding
1,418
New
876
Increased
102
Reduced
142
Closed
269

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$22.4M
2
QS icon
QuantumScape Corp
QS
+$15.9M
3
MP icon
MP Materials
MP
+$13.9M
4
RP
RealPage, Inc.
RP
+$13.5M
5
GPRE icon
Green Plains
GPRE
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.71%
2 Industrials 5%
3 Consumer Discretionary 4.69%
4 Technology 4.51%
5 Financials 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNS
751
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$379K 0.02%
25,000
+12,500
+100% +$181K
PAYA
752
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$379K 0.02%
34,224
-31,550
-48% -$402K
TER icon
753
PUT
Teradyne
TER
$54.8B
$377K 0.02%
+3,100
New +$389K
JNJ icon
754
Johnson & Johnson
JNJ
$635B
$375K 0.02%
2,269
+742
+49% +$120K
CTVA icon
755
PUT
Corteva
CTVA
$59.7B
$373K 0.02%
+8,000
New +$354K
WDAY icon
756
PUT
Workday
WDAY
$33.4B
$373K 0.02%
+1,500
New +$371K
EPAM icon
757
EPAM Systems
EPAM
$4.69B
$371K 0.02%
926
-9,538
-91% -$3.49M
AME icon
758
PUT
Ametek
AME
$55.5B
$370K 0.02%
+2,900
New +$350K
EW icon
759
PUT
Edwards Lifesciences
EW
$47.6B
$368K 0.02%
+4,400
New +$372K
SPY icon
760
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$368K 0.02%
928
-72
-7% -$27.8K
COP icon
761
ConocoPhillips
COP
$147B
$367K 0.02%
+6,902
New +$340K
ALGS icon
762
Aligos Therapeutics
ALGS
$25.2M
$364K 0.02%
+729
New +$485K
PKG icon
763
CALL
Packaging Corp of America
PKG
$22.7B
$363K 0.02%
+2,700
New +$368K
IIII
764
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$361K 0.02%
+36,401
New +$371K
HAL icon
765
Halliburton
HAL
$27.9B
$358K 0.02%
+16,773
New +$351K
JD icon
766
JD.com
JD
$40.8B
$356K 0.02%
+4,207
New +$386K
HES
767
CALL
DELISTED
Hess
HES
$354K 0.02%
+5,000
New +$320K
XPEV icon
768
XPeng
XPEV
$11.8B
$351K 0.02%
9,900
+3,400
+52% +$141K
O icon
769
PUT
Realty Income
O
$61.2B
$349K 0.02%
+5,676
New +$336K
OMER icon
770
Omeros
OMER
$709M
$348K 0.02%
19,159
-13,778
-42% -$268K
CL icon
771
PUT
Colgate-Palmolive
CL
$72.6B
$347K 0.02%
+4,400
New +$345K
AMTI
772
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$344K 0.02%
+7,876
New +$383K
DFNS.U
773
DELISTED
LGL Systems Acquisition Corp. Units
DFNS.U
$343K 0.02%
32,100
+17,100
+114% +$196K
MAS icon
774
PUT
Masco
MAS
$16B
$341K 0.02%
+5,700
New +$318K
GANX icon
775
Gain Therapeutics
GANX
$74.6M
$340K 0.02%
+22,124
New +$290K

Similar funds

Maven Securities's Q1 2021 Portfolio in Review

As of Q1 2021, Maven Securities held 1,418 positions worth $2.23B, up 121% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Maven Securities deployed $1.34B of net new capital in Q1 2021, opening 876 new positions and adding to 102 existing holdings. Its largest new stake was QuantumScape Corp: 303,111 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AdaptHealth, an estimated $18.2M trimmed.

  • Maven Securities's largest Q1 2021 buy was QuantumScape Corp: 303,111 shares worth $13.5M.
  • Maven Securities added most to Invesco QQQ Trust in Q1 2021, an estimated $22.4M increase.
  • Maven Securities's biggest Q1 2021 reduction was AdaptHealth, cutting an estimated $18.2M.
  • Maven Securities fully exited Adaptive Biotechnologies in Q1 2021, selling an estimated $25.6M.
  • Maven Securities's ten largest holdings make up 26% of its $2.23B portfolio in Q1 2021.
  • Maven Securities opened 876 new positions and closed 269 in Q1 2021.
  • Maven Securities's portfolio value rose 121% quarter-over-quarter to $2.23B.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.